245 related articles for article (PubMed ID: 21332170)
21. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
[TBL] [Abstract][Full Text] [Related]
22. Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222.
Greene RJ; Tu H; Gibbs JP; Greg Slatter J
Xenobiotica; 2011 Nov; 41(11):945-57. PubMed ID: 21867423
[TBL] [Abstract][Full Text] [Related]
23. Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization.
Xie H; Zeng L; Zeng S; Lu X; Zhang G; Zhao X; Cheng N; Tu Z; Li Z; Xu H; Yang L; Zhang X; Huang M; Zhao J; Hu W
Eur J Med Chem; 2012 Jun; 52():205-12. PubMed ID: 22475866
[TBL] [Abstract][Full Text] [Related]
24. Increased bioavailability of tricin-amino acid derivatives via a prodrug approach.
Ninomiya M; Tanaka K; Tsuchida Y; Muto Y; Koketsu M; Watanabe K
J Med Chem; 2011 Mar; 54(5):1529-36. PubMed ID: 21319803
[TBL] [Abstract][Full Text] [Related]
25. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
26. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
McGuigan C; Pathirana RN; Migliore M; Adak R; Luoni G; Jones AT; Díez-Torrubia A; Camarasa MJ; Velázquez S; Henson G; Verbeken E; Sienaert R; Naesens L; Snoeck R; Andrei G; Balzarini J
J Antimicrob Chemother; 2007 Dec; 60(6):1316-30. PubMed ID: 17956908
[TBL] [Abstract][Full Text] [Related]
27. Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics.
Chassaing C; Berger M; Heckeroth A; Ilg T; Jaeger M; Kern C; Schmid K; Uphoff M
J Med Chem; 2008 Mar; 51(5):1111-4. PubMed ID: 18271517
[TBL] [Abstract][Full Text] [Related]
28. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
Villhauer EB; Brinkman JA; Naderi GB; Burkey BF; Dunning BE; Prasad K; Mangold BL; Russell ME; Hughes TE
J Med Chem; 2003 Jun; 46(13):2774-89. PubMed ID: 12801240
[TBL] [Abstract][Full Text] [Related]
29. Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent.
Benzaria S; Pierra C; Bardiot D; Cretton-Scott E; Bridges EG; Zhou XJ; Standring D; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1003-6. PubMed ID: 14565331
[TBL] [Abstract][Full Text] [Related]
30. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.
Ohsumi K; Hatanaka T; Nakagawa R; Fukuda Y; Morinaga Y; Suga Y; Nihei Y; Ohishi K; Akiyama Y; Tsuji T
Anticancer Drug Des; 1999 Dec; 14(6):539-48. PubMed ID: 10834274
[TBL] [Abstract][Full Text] [Related]
32. Vildagliptin in clinical practice: a review of literature.
Banerjee M; Younis N; Soran H
Expert Opin Pharmacother; 2009 Nov; 10(16):2745-57. PubMed ID: 19874253
[TBL] [Abstract][Full Text] [Related]
33. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
34. ASP4000, a slow-binding dipeptidyl peptidase 4 inhibitor, has antihyperglycemic activity of long duration in Zucker fatty rats.
Tanaka-Amino K; Matsumoto K; Hatakeyama Y; Takakura S; Mutoh S
Acta Diabetol; 2010 Mar; 47(1):43-8. PubMed ID: 19238312
[TBL] [Abstract][Full Text] [Related]
35. Highly water-soluble lipophilic prodrugs of the anti-HIV nucleoside analogue 2',3'-dideoxycytidine and its 3'-fluoro derivative.
Kerr SG; Kalman TI
J Med Chem; 1992 May; 35(11):1996-2001. PubMed ID: 1317921
[TBL] [Abstract][Full Text] [Related]
36. Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.
Biftu T; Sinha-Roy R; Chen P; Qian X; Feng D; Kuethe JT; Scapin G; Gao YD; Yan Y; Krueger D; Bak A; Eiermann G; He J; Cox J; Hicks J; Lyons K; He H; Salituro G; Tong S; Patel S; Doss G; Petrov A; Wu J; Xu SS; Sewall C; Zhang X; Zhang B; Thornberry NA; Weber AE
J Med Chem; 2014 Apr; 57(8):3205-12. PubMed ID: 24660890
[TBL] [Abstract][Full Text] [Related]
37. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats.
Wang X; Zhang D; Xu W; Liu H; Wang W
Xenobiotica; 2010 Oct; 40(10):707-12. PubMed ID: 20735236
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability.
Brandl M; Wu X; Holper M; Hong L; Jia Z; Birudaraj R; Reddy M; Alfredson T; Tran T; Larrabee S; Hadig X; Sarma K; Washington C; Hill G; Smith DB
Drug Dev Ind Pharm; 2008 Jul; 34(7):683-91. PubMed ID: 18612909
[TBL] [Abstract][Full Text] [Related]
40. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
